In an article published on June 18, 2024 by Medical Economics, Brian Markovitz explains what the recent FTC rule banning noncompete agreements means for the future of the healthcare industry’s economy. The article details what the ban will do for competition and business growth, as well as the expected decrease in healthcare costs over the next decade. Markovitz also provides context for the ban, including the overwhelming support for the rule from healthcare employees and medical business entities.
Read the full article, “Why medical economics may change significantly if FTC noncompete ban is upheld,” in Medical Economics.
